Ardelyx Inc

FDA Filings

This page includes the latest FDA filings for Ardelyx Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NASDAQ

ARDX

DUNS 827436556

FDA Filings

Device Company	Device	Date
XPHOZAH 30 mg Ardelyx, Inc., Hovione Farmaciencia	Prescription Medication	2025-05-02
IBSRELA Ardelyx, Inc.	Prescription Medication	2025-03-23
XPHOZAH 30 mg Ardelyx, Inc., Hovione Farmaciencia	Prescription Medication	2025-01-01
XPHOZAH 30 mg Ardelyx, Inc., Hovione Farmaciencia	Prescription Medication	2024-12-19
XPHOZAH 30 mg Ardelyx, Inc., Hovione Farmaciencia	Prescription Medication	2023-11-09
IBSRELA Ardelyx, Inc.	Prescription Medication	2022-04-21
IBSRELA Ardelyx, Inc.	Prescription Medication	2021-06-05
IBSRELA Ardelyx, Inc.	Prescription Medication	2020-09-17
IBSRELA Ardelyx, Inc.	Prescription Medication	2020-04-09
IBSRELA Ardelyx, Inc.	Prescription Medication	2019-10-09
NDC 73154-050 Ardelyx, Inc.	IBSRELA	2019-09-12
211801 NDA ARDELYX INC		0000-00-00 00:00:00

Similar & Related FDA Registered Companies

• Hovione Farmaciencia

Related Finance Registrations

NCAGE Code	59BW4	ARDELYX, INC.
CAGE Code	59BW4	ARDELYX, INC.
SEC	0001437402	ARDELYX, INC. of DELAWARE